We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

VRTX Vertex Pharmaceuticals Inc

-3.65 (-1.03%)
Dec 01 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 1,135,006
Bid Price 348.56
Ask Price 353.00
News -
Day High 356.71


52 Week Range


Day Low 350.225
Share Name Share Symbol Market Stock Type
Vertex Pharmaceuticals Inc VRTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-3.65 -1.03% 351.16 19:00:00
Open Price Low Price High Price Close Price Previous Close
355.11 350.225 356.71 351.16 354.81
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
31,429 1,135,006 US$ 353.35 US$ 401,057,423 - 282.21 - 387.42
Last Trade Type Quantity Price Currency
18:51:25 4 US$ 353.62 USD

Vertex Pharmaceuticals (VRTX) Options Flow Summary

Overall Flow


Net Premium


Calls / Puts


Buys / Sells




Sweeps Ratio


Vertex Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
90.49B 257.68M - 8.99B 3.32B 12.89 27.24
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Vertex Pharmaceuticals News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No VRTX Message Board. Create One! See More Posts on VRTX Message Board See More Message Board Posts

Historical VRTX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week354.95356.71346.285351.311,250,947-3.79-1.07%
1 Month379.64387.42341.90360.531,578,497-28.48-7.5%
3 Months344.30387.42341.85359.821,213,8676.861.99%
6 Months324.47387.42320.01353.491,151,44826.698.23%
1 Year318.55387.42282.21331.911,199,37532.6110.24%
3 Years227.47387.42176.36257.491,584,235123.6954.38%
5 Years182.60387.42151.80242.811,550,401168.5692.31%

Vertex Pharmaceuticals Description

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |